Filed by ASP Isotopes Inc.
Pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-6
under the Securities Exchange Act of 1934
Subject Company: ENDRA Life Sciences Inc.
Commission File No.: 001-37969
Date: July 17, 2026
The following press release was issued by ASP Isotopes Inc. and ENDRA Life Sciences Inc. on July 17, 2026:
Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public... (continue reading...)
Filed by ENDRA Life Sciences Inc. pursuant to Rule 425
under the Securities Act of 1933, as amended,
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934, as amended
Subject Company: ENDRA Life Sciences Inc. (File No. 001-37969)
As previously disclosed, on June 25, 2026, ENDRA Life Sciences Inc., a Delaware corporation (“ENDRA”), entered into an Agreement and Plan of Merger, by and among ASP Isotopes Inc. (“ASPI”), a Delaware... (continue reading...)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
____________________________
Form 8-K
____________________________
Current... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13... (continue reading...)
http://archive.fast-edgar.com/20260717/A8ZZK22COZ228J8Z2M9H2ZZ29KQDZ22IZY82
Filed on: July 17, 2026
More SEC Filings
View Older Stories-
Form D Arrhen, Inc.
-
Form D Goodword Jan 2026 a Seri
-
Form D ANTR-6, a series of ALEX
-
Form D/A ITE Air Fund L.P.
-
Form 8-K INFINITY NATURAL RESOURC For: Jul 17
-
Form D/A Cogniate US Pre-Seed
-
Form 424B3 BANK OF NOVA SCOTIA
-
Form 3 JOHN WILEY & SONS, INC. For: Jul 09 Filed by: Scognamiglio Frank
-
Form 6-K Elevra Lithium Ltd For: Jul 17
-
Form 8-K Polaryx Therapeutics, For: Jul 16
-
Form 8-K Cocrystal Pharma, Inc. For: Jul 14
-
Form D/A BP 2026 AUTO a Series
-
Form D PARKWAY BANCORP INC/IL
-
Form 4 James Hardie Industries For: Jul 15 Filed by: Hill David Lawrence
-
Form 10-Q CLOUDASTRUCTURE, INC. For: Mar 31
-
Form D Shift Capital Apr 2026
-
Form D/A Sachem Head Offshore
-
Form D SSVPM26 a Series of CGF2
-
Form 4 MOGU Inc. For: Jul 13 Filed by: Chen Qi
-
Form D/A Sachem Head LP
-
Form D WITHAI2026 a Series of
-
Form D Kinetic Systems Apr 2026
-
Form D CFI26 a Series of CGF202
-
Form 13F-HR Arbejdsmarkedets Tillaeg For: Jun 30
-
Form 485BXT MEMBERS Life Insurance
-
Form 485BXT AIM COUNSELOR SERIES
-
Form 6-K ECARX Holdings Inc. For: Jul 17
-
Form D Peptomist Partex AI a
-
Form D Fortress Intellectual
-
Form 8-K FNB CORP/PA/ For: Jul 16
-
Form D Fortress Intellectual
-
Form D IGX 2 15 a Series of
-
Form 485BXT MEMBERS Life Insurance
-
Form 6-K Evaxion A/S For: Jul 17
-
Form 8-K SOUTH PLAINS FINANCIAL, For: Jul 16
-
Form 13F-HR Avanza Fonder AB For: Jun 30
-
Form D FF ACC8 Fund a Series
-
Form 1-A-W SAMARIUM GROUP Corp
-
Form 8-K Uniti Group Inc. For: Jul 15
-
Form 6-K GSK plc For: Jul 17
-
Form 4 Korro Bio, Inc. For: Jul 15 Filed by: Vincent Loic A
-
Form 8-K Solstice Advanced Materi For: Jul 17
-
Form 6-K Costamare Bulkers Holdin For: Jul 17
-
Form D SANJAY CAP XI a Series
-
Form 4 Korro Bio, Inc. For: Jul 15 Filed by: Dolan Oliver
-
Form DEF 14C Enhanced Group Inc. For: Jun 16
-
Form D Titan Moon SPV XIX 38402
-
Form 4 Korro Bio, Inc. For: Jul 15 Filed by: Cerio Jeffrey
-
Form 8-K Kalaris Therapeutics, For: Jul 17
-
Form 4 Korro Bio, Inc. For: Jul 15 Filed by: Chappell Todd
